Research Topics
| Mark StillmanSummaryAffiliation: Cleveland Clinic Foundation Country: USA Publications
| Collaborators
|
Detail Information
Publications
Endocrinology of cluster headache: potential for therapeutic manipulationMark Stillman
Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Curr Pain Headache Rep 12:138-44. 2008..We discuss these revelations, along with current clinical observations in headache and sleep medicine...
Steroid hormones in cluster headachesMark Stillman
Section of Headache and Facial Pain, Department of Neurology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Curr Pain Headache Rep 10:147-52. 2006..Future research may hold the key to a fuller explanation of the complex interaction of hormonal systems in the cluster headache...
Testosterone replacement therapy for treatment refractory cluster headacheMark J Stillman
Department of Neurology, Cleveland Clinic Foundation, 9500 Euclid Avenue, OH 44195, USA
Headache 46:925-33. 2006..Prospective studies pairing hormone levels and polysomnographic data are needed...
Pharmacotherapy of tension-type headachesMark J Stillman
Department of Neurology, Section of Headache and Pain, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195 0001, USA
Curr Pain Headache Rep 6:408-13. 2002..New research is emerging that points to the potential use of botulinum toxin and nitric synthase inhibitors. More scientifically rigorous clinical studies are needed...
Chemotherapy-induced peripheral neuropathyBushra Malik
Section of Headache and Pain, Department of Neurology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Curr Neurol Neurosci Rep 8:56-65. 2008....
Management of chemotherapy-induced peripheral neuropathyMark Stillman
Section of Headache and Facial Pain, Department of Neurology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Curr Pain Headache Rep 10:279-87. 2006..Preliminary studies have shown promise for some agents including glutamine, glutathione, vitamin E, acetyl-L-carnitine, calcium, and magnesium infusions, but final recommendations await prospective confirmatory studies...
Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case seriesLeonardo Kapural
Pain Management Department, Division of Anesthesiology, Cleveland Clinic, Cleveland, Ohio 44195, USA
Pain Pract 7:337-40. 2007..The functional capacity improvement measured by PDI was profound enough in the majority of the patients to allow patients to resume their regular daily activities for a period of time...
New developments in the pharmacotherapy of tension-type headachesChonghao Zhao
Department of Neurology, Section of Headache and Pain, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195 0001, USA
Expert Opin Pharmacother 4:2229-37. 2003..New research is now emerging that points to the potential utility of botulinum toxin type A, NMDA-receptor antagonists including Mg(2+) and nitric oxide synthase inhibitors. More scientifically rigorous clinical studies are needed...
Chemotherapy-induced peripheral neuropathyBushra Malik
Section of Headache and Pain, Department of Neurology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Curr Pain Headache Rep 12:165-74. 2008....
Clinical approach to patients with neuropathic painMark Stillman
Section of Headache and Facial Pain, Department of Neurology, Cleveland Clinic, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Cleve Clin J Med 73:726-8, 729-30, 733-6 passim. 2006..New antidepressants and anticonvulsants with novel mechanisms of action have spearheaded the way, and studies have finally shown that opioids are effective for treating chronic and breakthrough pain...
Treatment of primary headache disorders with intravenous valproate: initial outpatient experienceMark J Stillman
Department of Neurology, Division of Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
Headache 44:65-9. 2004..It appears to be an effective analgesic for identifiable primary headaches, especially episodic headache, and less effective for unclassifiable chronic headache. Randomized, double-blind, controlled studies are warranted...
